| Regression of glioblastoma after chimeric antigen receptor T-cell therapy CE Brown, D Alizadeh, R Starr, L Weng, JR Wagner, A Naranjo, ... New England Journal of Medicine 375 (26), 2561-2569, 2016 | 1673 | 2016 |
| Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma CE Brown, B Badie, ME Barish, L Weng, JR Ostberg, WC Chang, ... Clinical cancer research 21 (18), 4062-4072, 2015 | 735 | 2015 |
| The many HATs of transcription coactivators CE Brown, T Lechner, LA Howe, JL Workman Trends in biochemical sciences 25 (1), 15-19, 2000 | 528 | 2000 |
| Recruitment of HAT complexes by direct activator interactions with the ATM-related Tra1 subunit CE Brown, LA Howe, K Sousa, SC Alley, MJ Carrozza, S Tan, ... Science 292 (5525), 2333-2337, 2001 | 441 | 2001 |
| Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells KS Kahlon, C Brown, LJN Cooper, A Raubitschek, SJ Forman, ... Cancer research 64 (24), 9160-9166, 2004 | 439 | 2004 |
| T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia A Mardiros, C Dos Santos, T McDonald, CE Brown, X Wang, LE Budde, ... Blood, The Journal of the American Society of Hematology 122 (18), 3138-3148, 2013 | 430 | 2013 |
| Poly (A) tail length control in Saccharomyces cerevisiae occurs by message-specific deadenylation CE Brown, AB Sachs Molecular and cellular biology, 1998 | 390 | 1998 |
| Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL X Wang, LL Popplewell, JR Wagner, A Naranjo, MS Blanchard, MR Mott, ... Blood, The Journal of the American Society of Hematology 127 (24), 2980-2990, 2016 | 327 | 2016 |
| Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma KV Keu, TH Witney, S Yaghoubi, J Rosenberg, A Kurien, R Magnusson, ... Science translational medicine 9 (373), eaag2196, 2017 | 319 | 2017 |
| IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype D Alizadeh, RA Wong, X Yang, D Wang, JR Pecoraro, CF Kuo, B Aguilar, ... Cancer immunology research 7 (5), 759-772, 2019 | 309 | 2019 |
| Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain SJ Priceman, D Tilakawardane, B Jeang, B Aguilar, JP Murad, AK Park, ... Clinical Cancer Research 24 (1), 95-105, 2018 | 271 | 2018 |
| Neural stem cell–mediated enzyme/prodrug therapy for glioma: Preclinical studies KS Aboody, J Najbauer, MZ Metz, M D’Apuzzo, M Gutova, AJ Annala, ... Science translational medicine 5 (184), 184ra59-184ra59, 2013 | 264 | 2013 |
| Optimization of IL13Rα2-targeted chimeric antigen receptor T cells for improved anti-tumor efficacy against glioblastoma CE Brown, B Aguilar, R Starr, X Yang, WC Chang, L Weng, B Chang, ... Molecular Therapy 26 (1), 31-44, 2018 | 261 | 2018 |
| Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine–redirected T cells CE Brown, R Starr, B Aguilar, AF Shami, C Martinez, M D'Apuzzo, ... Clinical Cancer Research 18 (8), 2199-2209, 2012 | 253 | 2012 |
| PAN3 Encodes a Subunit of the Pab1p-Dependent Poly(A) Nuclease in Saccharomyces cerevisiae CE Brown, SZ Tarun Jr, R Boeck, AB Sachs Molecular and cellular biology 16 (10), 5744-5753, 1996 | 242 | 1996 |
| Transcription activator interactions with multiple SWI/SNF subunits KE Neely, AH Hassan, CE Brown, LA Howe, JL Workman Molecular and cellular biology 22 (6), 1615-1625, 2002 | 229 | 2002 |
| Targeting alpha-fetoprotein (AFP)–MHC complex with CAR T-cell therapy for liver cancer H Liu, Y Xu, J Xiang, L Long, S Green, Z Yang, B Zimdahl, J Lu, N Cheng, ... Clinical cancer research 23 (2), 478-488, 2017 | 223 | 2017 |
| Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy M Jonnalagadda, A Mardiros, R Urak, X Wang, LJ Hoffman, A Bernanke, ... Molecular Therapy 23 (4), 757-768, 2015 | 223 | 2015 |
| Chimeric antigen receptors T cell therapy in solid tumor: challenges and clinical applications HR Mirzaei, A Rodriguez, J Shepphird, CE Brown, B Badie Frontiers in immunology 8, 1850, 2017 | 214 | 2017 |
| Tumor PD-L1 co-stimulates primary human CD8+ cytotoxic T cells modified to express a PD1: CD28 chimeric receptor ME Prosser, CE Brown, AF Shami, SJ Forman, MC Jensen Molecular immunology 51 (3-4), 263-272, 2012 | 208 | 2012 |
